Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 1319822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline

  2008cited by this paper
• A DNA topoisomerase II-independent route for novobiocin-mediated resistance to DNA binding agents

  2008cited by this paper
• Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites.

  1991cited by this paper
• Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay.

  1991cited by this paper
• Abrogation by novobiocin of cytotoxicity due to the topoisomerase II inhibitor amsacrine in Chinese hamster cells.

  1990cited by this paper
• Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.

  1989cited by this paper
• Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression.

  1989cited by this paper
• Multidrug resistance.

  1988cited by this paper
• Glutathione contents in human and rodent tumor cells in various phases of the cell cycle.

  1988cited by this paper
• Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.

  1987cited by this paper
• Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase.

  1987cited by this paper
• Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.

  1987cited by this paper
• Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells.

  1987cited by this paper
• Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.

  1987cited by this paper
• Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

  1987cited by this paper
• Recent studies of DNA topoisomerases.

  1987cited by this paper
• Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.

  1987cited by this paper
• Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.

  1986cited by this paper
• Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper
• Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerases.

  1985cited by this paper
• Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

  1984cited by this paper
• Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.

  1982cited by this paper
• Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid.

  1981cited by this paper
• Novobiocin inhibition of simian virus 40 DNA replication

  1980cited by this paper
• An experimental and analytical study of oxygen depletion in stirred cell suspensions.

  1980cited by this paper
• Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.

  1976cited by this paper
• DNA gyrase: an enzyme that introduces superhelical turns into DNA.

  1976cited by this paper
• Lethal effect of adriamycin on the division cycle of HeLa cells.

  1972cited by this paper

• A novel indeno[1,2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity.

  2017cites this paper
• The HSP90 and DNA topoisomerase VI inhibitor radicicol also inhibits human type II DNA topoisomerase.

  2006cites this paper
• Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells

  2005cites this paper
• Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs

  2005cites this paper
• Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo

  2004cites this paper
• Relationship between cell size, cell cycle and specific recombinant protein productivity

  2000cites this paper
• Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study.

  2000cites this paper
• Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies.

  2000cites this paper
• Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures.

  1999cites this paper
• Influence of novobiocin on g -irradiation G0-lymphocytes as analyzed by cytogenetic endpoints

  1999cites this paper
• Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.

  1998cites this paper
• INFLUENCE OF NOVOBIOCIN ON γ-IRRADIATED G 0-LYMPHOCYTES AS ANALYZED BY CYTOGENETIC ENDPOINTS

  1998cites this paper
• DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.

  1997cites this paper
• MULTIDRUG RESISTANCE IN LEUKAEMIA

  1997cites this paper
• Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.

  1996cites this paper
• Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.

  1996cites this paper
• The effects of interleukin-1 beta and tumor necrosis factor-alpha on in vitro colony formation by human hematopoietic progenitor cells exposed to doxorubicin or hydroquinone.

  1995cites this paper
• Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer.

  1995cites this paper
• Cell cycle phase-dependent cytotoxicity of actinomycin D in HeLa cells.

  1994cites this paper
• Effects of novobiocin on the induction of gamma-glutamyltranspeptidase positive foci in the liver of rats treated with diethylnitrosamine.

  1994cites this paper
• Determination of plasma novobiocin levels by a reversed-phase high-performance liquid chromatographic assay.

  1994cites this paper
• Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro.

  1994cites this paper
• Rapid and sensitive high-performance liquid chromatographic assay for novobiocin in human serum.

  1994cites this paper
• Inhibition of topoisomerase II by aurintricarboxylic acid: implications for mechanisms of apoptosis.

  1994cites this paper
• Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine

  1993cites this paper
• Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin.

  1993cites this paper
• Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.

  1993cites this paper
• Multidrug resistance in leukaemia.

  1992cites this paper